Investigator
Alex Rojas Bie Thomsen
UNCO THERAPEUTICS LLC · funded by NIGMS
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $753k
- First award
- Sep 1, 2022
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 16, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- UNCO THERAPEUTICS LLC31momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R41
Development of Allosteric Uncouplers as Therapeutics for Chronic Pain
$350kSep 16, 2025NIGMSUNCO THERAPEUTICS LLCNIH RePORTER · 11253679 (opens the source filing in a new tab)
- R35
Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations
$403kSep 1, 2022NIGMSNEW YORK UNIVERSITYNIH RePORTER · 11190936 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources